Search Results - "for PRESTIGIO Study Group"

Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus.

Authors: Castagna, Antonella Ferrara, Micol Galli, Laura et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Jan2018, Vol. 73 Issue 1, p177-182. 6p. 2 Charts, 2 Graphs.